TherapeuticsMD Inc (NASDAQ:TXMD)

5.37
Delayed Data
As of Feb 23
 +0.36 / +7.19%
Today’s Change
3.50
Today|||52-Week Range
8.30
-11.09%
Year-to-Date

Today’s Trading

Previous close5.01
Today’s open5.01
Day’s range4.96 - 5.38
Volume1,686,129
Average volume (3 months)2,777,656
Market cap$1.2B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+19.57%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)-13.32%
P/E ratioNM
Price/Sales73.99
Price/Book8.95

Competitors

 Today’s
change
Today’s
% change
AKCAAkcea Therapeutics I...+0.32+1.46%
ESPREsperion Therapeutic...+0.96+1.23%
BHVNBiohaven Pharmaceuti...+2.04+6.57%
FWPForward Pharma A/S-0.12-3.95%
Data as of 4:02pm ET, 02/23/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$16.8M
Annual profit (last year)-$76.9M
Net profit margin-458.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts